What should you know about Sovaldi and hepatitis C?

Hepatitis C is a viral infection that can affect the liver. Sofosbuvir works against a hepatitis C protein needed for the virus to multiply. Treatment plans commonly combine it with another antiviral, and the choice depends on the virus type, liver health, previous treatment, and other medicines.

Some people have no symptoms, while others notice fatigue or other signs of liver illness. A prescription should not be shared, and stopping treatment early can make the plan less effective or complicate follow-up.

Arrange a GP Consultation or specialist review before starting, changing, or stopping treatment. Give the clinician a complete list of medicines, supplements, and health conditions because interactions can affect treatment choices. Take doses exactly as prescribed and discuss a missed dose rather than doubling up.

Follow-up may include blood tests to check liver health and to assess the response to treatment. A Liver Function Test is one way clinicians monitor how the liver is working, but it does not replace the broader hepatitis C assessment.

Contact a clinician promptly for yellowing of the skin or eyes, very dark urine, unusual bleeding, severe abdominal swelling, confusion, or a serious reaction after taking a medicine. Seek emergency help for breathing difficulty or swelling of the face or throat.

Ask which hepatitis C type is being treated, how long the planned course lasts, which interactions matter, and which tests will confirm the outcome.